AIMD: Ainos, Inc. Stock

by  •  • Comments Off on AIMD: Ainos, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 8.03
Enterprise Value ($M) 15.14
Book Value ($M) 18.02
Book Value / Share 1.30
Price / Book 0.45
NCAV ($M) -7.70
NCAV / Share -0.56
Price / NCAV -1.04

Profitability (mra)
Return on Invested Capital (ROIC) -0.53
Return on Assets (ROA) -0.51
Return on Equity (ROE) -0.66

Liquidity (mrq)
Quick Ratio 1.33
Current Ratio 1.37

Balance Sheet (mrq) ($M)
Current Assets 5.65
Assets 31.37
Liabilities 13.35
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-27 13D/A Ainos Inc 16.89 0.00
08-21 13D Taiwan Carbon Nano Technology Corp 40.23
05-08 13D Advanced Semiconductor Engineering Inc 27.40
05-06 13D/A Amarillo Biosciences Inc 63.36 76.37

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-03-08 10-K U.S. Securities and Exchange Commission Washington, D.C. 20549 FORM 10-K
2024-02-15 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-01-14 472,970 1,165,635 40.58
2025-01-13 263,839 992,747 26.58
2025-01-10 6,334,019 16,307,786 38.84

(click for more detail)

Similar Companies
ADTX – Aditxt, Inc. ADVM – Adverum Biotechnologies, Inc.
AGEN – Agenus Inc. AKAN – Akanda Corp.
AKBA – Akebia Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io